These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Propensity Score Analysis Comparing Clinical Outcomes of Drug-Eluting vs Bare Nitinol Stents in Femoropopliteal Lesions. Soga Y, Takahara M, Iida O, Nakano M, Yamauchi Y, Zen K, Kawasaki D, Ando K. J Endovasc Ther; 2016 Feb; 23(1):33-9. PubMed ID: 26763256 [Abstract] [Full Text] [Related]
27. Randomized trial of Legflow(®) paclitaxel eluting balloon and stenting versus standard percutaneous transluminal angioplasty and stenting for the treatment of intermediate and long lesions of the superficial femoral artery (RAPID trial): study protocol for a randomized controlled trial. Karimi A, de Boer SW, van den Heuvel DA, Fioole B, Vroegindeweij D, Heyligers JM, Lohle PN, Elgersma O, Nolthenius RP, Vos JA, de Vries JP. Trials; 2013 Mar 28; 14():87. PubMed ID: 23537403 [Abstract] [Full Text] [Related]
28. The 24-Month Results of the Lutonix Global SFA Registry: Worldwide Experience With Lutonix Drug-Coated Balloon. Thieme M, Von Bilderling P, Paetzel C, Karnabatidis D, Perez Delgado J, Lichtenberg M, Lutonix Global SFA Registry Investigators. JACC Cardiovasc Interv; 2017 Aug 28; 10(16):1682-1690. PubMed ID: 28780030 [Abstract] [Full Text] [Related]
29. Paclitaxel-coated balloon angioplasty versus drug-eluting stenting for the treatment of infrapopliteal long-segment arterial occlusive disease: the IDEAS randomized controlled trial. Siablis D, Kitrou PM, Spiliopoulos S, Katsanos K, Karnabatidis D. JACC Cardiovasc Interv; 2014 Sep 28; 7(9):1048-56. PubMed ID: 25234679 [Abstract] [Full Text] [Related]
31. Efficacy of Rotational Atherectomy Followed by Drug-coated Balloon Angioplasty for the Treatment of Femoropopliteal Lesions-Comparison with Sole Drug-coated Balloon Revascularization: Two-year Outcomes. Rodoplu O, Oztas DM, Meric M, Beyaz MO, Ulukan MO, Yildiz CE, Unal O, Ugurlucan M. Ann Vasc Surg; 2021 May 28; 73():222-233. PubMed ID: 33359329 [Abstract] [Full Text] [Related]
32. Paclitaxel-Coated Balloon vs Uncoated Balloon Angioplasty for Treatment of In-Stent Restenosis in the Superficial Femoral and Popliteal Arteries: The COPA CABANA Trial. Tepe G, Schroeder H, Albrecht T, Reimer P, Diehm N, Baeriswyl JL, Brechtel K, Speck U, Zeller T. J Endovasc Ther; 2020 Apr 28; 27(2):276-286. PubMed ID: 32096451 [Abstract] [Full Text] [Related]
34. Comparison of drug-coated balloon angioplasty versus uncoated balloon angioplasty in treatment of total occlusions with severe femoropopliteal lesions: An additional analysis from the AcoArt I study. Sun G, Liu J, Jia S, Zhang J, Zhuang B, Jia X, Fu W, Wu D, Wang F, Zhao Y, Guo P, Bi W, Wang S, Guo W, AcoArt I Trial Investigators. Vascular; 2021 Jun 28; 29(3):340-349. PubMed ID: 32903168 [Abstract] [Full Text] [Related]
35. Comparative 12-Month Outcomes of Drug-Coated Balloon Versus Non-Drug-Coated Balloon Revascularization Strategy in Chronic Limb-Threatening Ischemia: Results From the XLPAD Registry. Giannopoulos S, Jeon-Slaughter H, Kahlon RS, Tejani I, Baskar A, Banerjee S, Armstrong EJ. Cardiovasc Revasc Med; 2020 Oct 28; 21(10):1276-1284. PubMed ID: 32249170 [Abstract] [Full Text] [Related]
36. Long-Term Clinical Effectiveness of a Drug-Coated Balloon for the Treatment of Femoropopliteal Lesions. Laird JA, Schneider PA, Jaff MR, Brodmann M, Zeller T, Metzger DC, Krishnan P, Scheinert D, Micari A, Wang H, Masters M, Tepe G. Circ Cardiovasc Interv; 2019 Jun 28; 12(6):e007702. PubMed ID: 31195825 [Abstract] [Full Text] [Related]
37. Randomized Trial Comparing a Stent-Avoiding With a Stent-Preferred Strategy in Complex Femoropopliteal Lesions. Wittig T, Schmidt A, Fuß T, Thieme M, Maiwald L, Düsing S, Konert M, Fischer A, Scheinert D, Steiner S. JACC Cardiovasc Interv; 2024 May 13; 17(9):1134-1144. PubMed ID: 38749594 [Abstract] [Full Text] [Related]
38. 12-month primary patency rates of contemporary endovascular device therapy for femoro-popliteal occlusive disease in 6,024 patients: beyond balloon angioplasty. Marmagkiolis K, Hakeem A, Choksi N, Al-Hawwas M, Edupuganti MM, Leesar MA, Cilingiroglu M. Catheter Cardiovasc Interv; 2014 Oct 01; 84(4):555-64. PubMed ID: 24740749 [Abstract] [Full Text] [Related]
39. Paclitaxel-Eluting Balloon vs Standard Angioplasty to Reduce Restenosis in Diabetic Patients With In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Arteries: Three-Year Results of the DEBATE-ISR Study. Grotti S, Liistro F, Angioli P, Ducci K, Falsini G, Porto I, Ricci L, Ventoruzzo G, Turini F, Bellandi G, Bolognese L. J Endovasc Ther; 2016 Feb 01; 23(1):52-7. PubMed ID: 26511896 [Abstract] [Full Text] [Related]
40. 2-year results of paclitaxel-eluting balloons for femoropopliteal artery disease: evidence from a multicenter registry. Micari A, Cioppa A, Vadalà G, Castriota F, Liso A, Marchese A, Grattoni C, Pantaleo P, Cremonesi A, Rubino P, Biamino G. JACC Cardiovasc Interv; 2013 Mar 01; 6(3):282-9. PubMed ID: 23517840 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]